Home › Rheumatoid Arthritis › Pennsylvania
Rheumatoid Arthritis clinical trials in Pennsylvania
10 studies for Rheumatoid Arthritis are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
RA-PRO PRAGMATIC TRIAL
- Altoona Center for Clinical Research, Duncansville
- Rheumatology and Arthritis Care Center, Exton
- Allegheny Health Network, Pittsburgh
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT04692493Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
- Local Institution - 0071, Philadelphia
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Sep 22, 2026 · NCT07412704A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
- Altoona Center For Clinical Research /ID# 272479, Duncansville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06972446A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
- Altoona Center For Clinical Research, Duncansville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07137598Phase 1b/2 Study of IV Sarilumab in Adult With RA
- Altoona Center for Clinical Research - Duncansville- Site Number : 8400007, Duncansville
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT07704580R-2487 in Patients With Rheumatoid Arthritis
- Altoona Center for Research, Duncansville
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Jun 12, 2026 · NCT05961592Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
RecruitingObservational study
2 Months – 60 Years · All sexes · Updated Jan 13, 2026 · NCT04528355A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis
- Altoona Center for Clinical Research, Duncansville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 6, 2025 · NCT06671054ConsideRAte Study - Splenic Stimulation for RA
- Altoona Center for Clinical Research, Altoona
Recruiting
Ages 22 to 75 · All sexes · Updated May 22, 2024 · NCT05003310From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.